Cubist Systematic Strategies’s Genocea Biosciences, Inc. GNCA Stock Holding History

Cubist Systematic Strategies’s Portfolio GNCA Stock Details GNCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-900	Closed	-$1K	–	4754
2022 Q1	$1K	Buy	+900	New	+$980	﹤0.01%	3523
2019 Q3	–	Sell	-10,099	Closed	-$40K	–	2674
2019 Q2	$40K	Buy	+10,099	New	+$52.7K	﹤0.01%	2348

Other funds holding GNCA

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

AICPI

ABG Innovation Capital Partners III Central, Hong Kong, Hong Kong $64.5K AUM 1.01% 1-Year Est. Return

Cubist Systematic Strategies's GNCA Position: Q2 2022 in Review

Cubist Systematic Strategies sold out of Genocea Biosciences, Inc. (GNCA) in Q2 2022, closing a stake of 900 shares — an estimated $1K sold.

Cubist Systematic Strategies first reported a position in GNCA in Q2 2019 and held it in 2 quarters. The position peaked at $40K in Q2 2019. 5 funds tracked by Wall St. Rank hold GNCA as of Q2 2022.

Cubist Systematic Strategies reported no remaining Genocea Biosciences, Inc. position as of Q2 2022 after selling out during the quarter.
Cubist Systematic Strategies sold 900 Genocea Biosciences, Inc. shares in Q2 2022, an estimated $1K.
Cubist Systematic Strategies first reported a position in Genocea Biosciences, Inc. in Q2 2019 and held it in 2 quarters.
Cubist Systematic Strategies's Genocea Biosciences, Inc. position peaked at $40K in Q2 2019.
5 funds tracked by Wall St. Rank held Genocea Biosciences, Inc. as of Q2 2022.

Based on Cubist Systematic Strategies's 13F filing for Q2 2022, filed 15 Aug 2022.